AZZALURE 2X125IU

Description

AZZALURE 2X125IU Azzalure is a local muscle relaxant adapted from the botulinum toxin type-A of Dysport and is specifically designed for use in aesthetic indications.
Azzalure is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows) seen at frown, in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

AZZALURE 2X125IU Azzalure was previously marketed under the brand name Dysport, but licensed only to treat medical conditions such as cerebral palsy, facial tics and strokes – but it can now be used for cosmetic use.

AZZALURE 2X125IU Both drugs contain protein called botulinum toxin, which is produced by the bacterium Clostridium botulinum. In large doses the protein can cause botulism, a rare illness often linked to food poisoning.
But in small doses, injected into the face, it simply blocks a chemical that tells the muscles to contract. By stopping the face from frowning, the wrinkles caused by these expressions are effectively ironed out.

AZZALURE 2X125IU But in small doses, injected into the face, it simply blocks a chemical that tells the muscles to contract. By stopping the face from frowning, the wrinkles caused by these expressions are effectively ironed out.
The advantage of Azzalure is that it is significantly cheaper than Botox

Botox has a bigger molecular structure which does not diffuse in the tissue as far as Azzalure

This means that the accuracy of an injection around the eye, for example, is far greater as it is less likely for the toxin to travel away from the site of injection, causing a droopy eyelid or eyebrow

Azzalure is a local muscle relaxant adapted from the botulinum toxin type-A of Dysport and is specifically designed for use in aesthetic indications.
Azzalure is indicated for the temporary improvement in the appearance of moderate to severe glabellar lines (vertical lines between the eyebrows) seen at frown, in adult patients under 65 years, when the severity of these lines has an important psychological impact on the patient.

Azzalure was previously marketed under the brand name Dysport, but licensed only to treat medical conditions such as cerebral palsy, facial tics and strokes – but it can now be used for cosmetic use.

Both drugs contain protein called botulinum toxin, which is produced by the bacterium Clostridium botulinum. In large doses the protein can cause botulism, a rare illness often linked to food poisoning.
But in small doses, injected into the face, it simply blocks a chemical that tells the muscles to contract. By stopping the face from frowning, the wrinkles caused by these expressions are effectively ironed out.